130 ALS clusters – toxins and stressors that deplete or need vitamin D

Summary of ALS Clusters: Common Patterns — TrialSite News July, 2026

URL by Claude AI

This is an opinion article in which Kostoff used AI tools (primarily Gemini) to assemble and analyze a master registry of 130 documented ALS clusters from the U.S. and around the world, then looked for recurring patterns. It follows a similar cancer-cluster analysis he published earlier.

Central argument: The way public-health agencies (CDC, ATSDR) track ALS clusters is structurally flawed. Their spatial-scan methods (e.g., SaTScan) define a cluster by geographic and temporal proximity at the time of diagnosis. Because sporadic ALS (~90% of cases) has a latency of 10–40 years, victims have usually moved far from the original exposure by the time symptoms appear — so real environmental and occupational clusters get diluted into background noise or dismissed. He argues epidemiology should shift to an "exposome-centric" model based on shared lifetime exposures rather than shared zip codes.

The 130 clusters fall into recurring categories:

Cyanotoxin / waterborne — BMAA and related toxins from algal blooms (e.g., Lake Mascoma NH, Lake Champlain VT, Chesapeake Bay, Guam).
Heavy metals / metalloids — inorganic selenium, lead, cadmium, manganese (e.g., Reggio Emilia Italy, smelting and mining zones).
Agricultural chemicals — organophosphates, organochlorines like hexachlorobenzene, glyphosate (farm belts in the U.S. and Europe).
Occupational / traumatic / athletic — Gulf War veterans, pro soccer and NFL players, electrical workers, solvent-exposed trades. These are "dispersed clusters": mechanistically identical but geographically scattered, so they stay invisible to standard tracking.
Historic endemic foci — Guam, Kii Peninsula (Japan), West Papua, the false-morel cluster in the French Alps.

Common mechanisms converge on oxidative stress, mitochondrial dysfunction, protein misfolding (TDP-43), and glutamate excitotoxicity — often amplified by gene–environment interactions (e.g., the NAT2 slow-acetylator variant in the French Alps mushroom cluster) and by chemical mixtures rather than single agents. He notes that exertion alone does not cause ALS (cyclists and basketball players show no elevated risk), pointing instead to repetitive head trauma plus chemical exposure.

Why this matters for vitamin D

Kostoff frames ALS as the endpoint of accumulated stressors — toxins, trauma, and chemical mixtures — interacting with genetic vulnerability. That is essentially the stressor model VitaminDWiki has used for years. Many of his cluster triggers (pesticides, heavy metals, repetitive trauma) are already tracked here as stressors that vitamin D is thought to help counter, and the biological pathways he lists — oxidative stress, neuroinflammation, mitochondrial dysfunction, excitotoxicity, and TDP-43 misfolding — overlap heavily with those vitamin D is argued to modulate. His report does not mention vitamin D, but the mechanisms he describes are exactly where the vitamin D case for ALS has been made.

Epilog — iatrogenic ALS (the most controversial section): Kostoff appends a verbatim AI-generated assessment arguing that drug- and procedure-induced ALS is systematically underexplored — implicating statins (pharmacovigilance signals in VigiBase and FAERS), psychiatric medications (a 2025 JAMA Network Open case-control study), chemotherapy agents, Gulf War and COVID-19 vaccines, and pharmaceutical contaminants. These are presented as unresolved "safety signals," and much of this rests on case reports, disproportionality analyses, and mechanistic plausibility rather than established causation.

Note for readers: This is a clearly labeled opinion piece. The pattern analysis is a useful synthesis, but a number of claims — especially in the iatrogenic epilog — are contested and not established consensus; the author himself frames several as signals requiring further study.

Related in VitaminDWiki include:

Amyotrophic Lateral Sclerosis